Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005730 | nucleolus | 5 | 1 |
GO:0005732 | sno(s)RNA-containing ribonucleoprotein complex | 3 | 1 |
GO:0030684 | preribosome | 3 | 1 |
GO:0031428 | box C/D RNP complex | 4 | 1 |
GO:0032040 | small-subunit processome | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: A4H9W7
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006364 | rRNA processing | 8 | 7 |
GO:0006396 | RNA processing | 6 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0016070 | RNA metabolic process | 5 | 7 |
GO:0016072 | rRNA metabolic process | 7 | 7 |
GO:0032259 | methylation | 2 | 7 |
GO:0034470 | ncRNA processing | 7 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0034660 | ncRNA metabolic process | 6 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0090304 | nucleic acid metabolic process | 4 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:0000154 | rRNA modification | 6 | 1 |
GO:0000494 | box C/D RNA 3'-end processing | 10 | 1 |
GO:0001510 | RNA methylation | 4 | 1 |
GO:0006479 | protein methylation | 4 | 1 |
GO:0008213 | protein alkylation | 5 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0016074 | sno(s)RNA metabolic process | 7 | 1 |
GO:0016570 | histone modification | 5 | 1 |
GO:0016571 | histone methylation | 5 | 1 |
GO:0018364 | peptidyl-glutamine methylation | 5 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0031123 | RNA 3'-end processing | 7 | 1 |
GO:0031126 | sno(s)RNA 3'-end processing | 9 | 1 |
GO:0031167 | rRNA methylation | 5 | 1 |
GO:0033967 | box C/D RNA metabolic process | 8 | 1 |
GO:0034963 | box C/D RNA processing | 9 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043144 | sno(s)RNA processing | 8 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043414 | macromolecule methylation | 3 | 1 |
GO:0043628 | regulatory ncRNA 3'-end processing | 8 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1990258 | histone glutamine methylation | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0003723 | RNA binding | 4 | 7 |
GO:0003824 | catalytic activity | 1 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0008168 | methyltransferase activity | 4 | 7 |
GO:0016740 | transferase activity | 2 | 7 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
GO:0008170 | N-methyltransferase activity | 5 | 1 |
GO:0008173 | RNA methyltransferase activity | 4 | 1 |
GO:0008276 | protein methyltransferase activity | 3 | 1 |
GO:0008649 | rRNA methyltransferase activity | 5 | 1 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 1 |
GO:0036009 | protein-glutamine N-methyltransferase activity | 4 | 1 |
GO:0042054 | histone methyltransferase activity | 4 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140102 | catalytic activity, acting on a rRNA | 4 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
GO:1990259 | histone H2AQ104 methyltransferase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 106 | 108 | PF00675 | 0.694 |
CLV_NRD_NRD_1 | 318 | 320 | PF00675 | 0.516 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.676 |
CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.686 |
CLV_PCSK_KEX2_1 | 231 | 233 | PF00082 | 0.369 |
CLV_PCSK_KEX2_1 | 317 | 319 | PF00082 | 0.508 |
CLV_PCSK_PC1ET2_1 | 101 | 103 | PF00082 | 0.566 |
CLV_PCSK_PC1ET2_1 | 231 | 233 | PF00082 | 0.369 |
CLV_PCSK_PC1ET2_1 | 317 | 319 | PF00082 | 0.410 |
CLV_PCSK_PC7_1 | 102 | 108 | PF00082 | 0.556 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.478 |
DEG_SPOP_SBC_1 | 36 | 40 | PF00917 | 0.483 |
DOC_ANK_TNKS_1 | 218 | 225 | PF00023 | 0.357 |
DOC_MAPK_DCC_7 | 219 | 227 | PF00069 | 0.357 |
DOC_MAPK_gen_1 | 317 | 325 | PF00069 | 0.369 |
DOC_MAPK_gen_1 | 405 | 412 | PF00069 | 0.368 |
DOC_MAPK_MEF2A_6 | 219 | 227 | PF00069 | 0.373 |
DOC_PP2B_LxvP_1 | 42 | 45 | PF13499 | 0.470 |
DOC_USP7_MATH_1 | 223 | 227 | PF00917 | 0.357 |
DOC_USP7_MATH_1 | 238 | 242 | PF00917 | 0.235 |
DOC_USP7_MATH_1 | 251 | 255 | PF00917 | 0.266 |
DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.488 |
DOC_USP7_MATH_1 | 45 | 49 | PF00917 | 0.441 |
DOC_USP7_MATH_1 | 69 | 73 | PF00917 | 0.497 |
DOC_USP7_MATH_2 | 406 | 412 | PF00917 | 0.369 |
DOC_WW_Pin1_4 | 189 | 194 | PF00397 | 0.595 |
LIG_14-3-3_CanoR_1 | 41 | 45 | PF00244 | 0.478 |
LIG_14-3-3_CanoR_1 | 59 | 67 | PF00244 | 0.443 |
LIG_14-3-3_CanoR_1 | 80 | 86 | PF00244 | 0.490 |
LIG_Actin_WH2_2 | 19 | 36 | PF00022 | 0.478 |
LIG_APCC_ABBA_1 | 225 | 230 | PF00400 | 0.369 |
LIG_BRCT_BRCA1_1 | 242 | 246 | PF00533 | 0.357 |
LIG_FHA_1 | 216 | 222 | PF00498 | 0.366 |
LIG_FHA_1 | 50 | 56 | PF00498 | 0.464 |
LIG_FHA_1 | 86 | 92 | PF00498 | 0.500 |
LIG_IBAR_NPY_1 | 250 | 252 | PF08397 | 0.369 |
LIG_LIR_Apic_2 | 266 | 271 | PF02991 | 0.357 |
LIG_LIR_Gen_1 | 112 | 119 | PF02991 | 0.518 |
LIG_LIR_Gen_1 | 344 | 353 | PF02991 | 0.420 |
LIG_LIR_Gen_1 | 52 | 60 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 112 | 117 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 258 | 264 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 344 | 350 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 423 | 429 | PF02991 | 0.379 |
LIG_LIR_Nem_3 | 52 | 57 | PF02991 | 0.469 |
LIG_MYND_3 | 323 | 327 | PF01753 | 0.357 |
LIG_Pex14_2 | 114 | 118 | PF04695 | 0.519 |
LIG_Pex14_2 | 54 | 58 | PF04695 | 0.473 |
LIG_SH2_CRK | 261 | 265 | PF00017 | 0.464 |
LIG_SH2_CRK | 335 | 339 | PF00017 | 0.516 |
LIG_SH2_CRK | 426 | 430 | PF00017 | 0.520 |
LIG_SH2_STAP1 | 300 | 304 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 208 | 211 | PF00017 | 0.490 |
LIG_SH2_STAT5 | 277 | 280 | PF00017 | 0.369 |
LIG_SH3_3 | 245 | 251 | PF00018 | 0.470 |
LIG_SH3_3 | 347 | 353 | PF00018 | 0.369 |
LIG_WW_3 | 93 | 97 | PF00397 | 0.500 |
MOD_CDK_SPK_2 | 189 | 194 | PF00069 | 0.595 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.368 |
MOD_CK1_1 | 226 | 232 | PF00069 | 0.291 |
MOD_CK1_1 | 282 | 288 | PF00069 | 0.457 |
MOD_CK1_1 | 305 | 311 | PF00069 | 0.358 |
MOD_CK1_1 | 32 | 38 | PF00069 | 0.485 |
MOD_CK1_1 | 40 | 46 | PF00069 | 0.467 |
MOD_CK1_1 | 61 | 67 | PF00069 | 0.472 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.573 |
MOD_GlcNHglycan | 257 | 260 | PF01048 | 0.391 |
MOD_GlcNHglycan | 272 | 275 | PF01048 | 0.242 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.288 |
MOD_GlcNHglycan | 307 | 310 | PF01048 | 0.371 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.475 |
MOD_GlcNHglycan | 401 | 404 | PF01048 | 0.357 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.479 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.481 |
MOD_GSK3_1 | 251 | 258 | PF00069 | 0.410 |
MOD_GSK3_1 | 313 | 320 | PF00069 | 0.357 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.453 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.463 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.494 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.524 |
MOD_N-GLC_1 | 233 | 238 | PF02516 | 0.357 |
MOD_N-GLC_2 | 205 | 207 | PF02516 | 0.357 |
MOD_NEK2_1 | 373 | 378 | PF00069 | 0.362 |
MOD_NEK2_1 | 399 | 404 | PF00069 | 0.358 |
MOD_NEK2_1 | 58 | 63 | PF00069 | 0.477 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.498 |
MOD_NEK2_2 | 223 | 228 | PF00069 | 0.369 |
MOD_NEK2_2 | 263 | 268 | PF00069 | 0.369 |
MOD_OFUCOSY | 87 | 93 | PF10250 | 0.502 |
MOD_PKA_1 | 317 | 323 | PF00069 | 0.357 |
MOD_PKA_2 | 317 | 323 | PF00069 | 0.357 |
MOD_PKA_2 | 40 | 46 | PF00069 | 0.480 |
MOD_PKA_2 | 58 | 64 | PF00069 | 0.447 |
MOD_Plk_2-3 | 408 | 414 | PF00069 | 0.369 |
MOD_Plk_4 | 223 | 229 | PF00069 | 0.357 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.412 |
MOD_Plk_4 | 49 | 55 | PF00069 | 0.463 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.468 |
MOD_ProDKin_1 | 189 | 195 | PF00069 | 0.583 |
TRG_ENDOCYTIC_2 | 261 | 264 | PF00928 | 0.464 |
TRG_ENDOCYTIC_2 | 335 | 338 | PF00928 | 0.516 |
TRG_ENDOCYTIC_2 | 426 | 429 | PF00928 | 0.522 |
TRG_ER_diArg_1 | 105 | 107 | PF00400 | 0.693 |
TRG_Pf-PMV_PEXEL_1 | 310 | 314 | PF00026 | 0.369 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8ID71 | Leishmania donovani | 99% | 100% |
A0A3S5H830 | Leishmania donovani | 68% | 100% |
E9AGR2 | Leishmania infantum | 99% | 100% |
E9ARW1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 99% | 100% |
Q4QDL1 | Leishmania major | 99% | 100% |